Critical Care Medicine
1. Description of the problem
What every clinician needs to know
Hypoglycemia may be associated with mortality and neurologic complications such as seizures and coma.
It is uncertain what the clinical consequences from hypoglycemia are in ICU patients.
In diabetes patients, hypoglycemia is associated with:
Diverse symptoms such as anxiety, palpitations, tremor, sweating, hunger and paresthesias.
Neurologic symptoms such as behavioral changes, cognitive dysfunction, seizures and coma.
Key management points
Stop insulin infusion.
Check blood glucose within 30-60 minutes.
2. Emergency Management
Emergency management steps
Stop insulin infusion (and oral antidiabetic agents).
Administer 10 to 20 mL Glucose 50% intravenously.
Check blood glucose concentration within 30 to 60 minutes.
Drugs and dosages
Establishing a specific diagnosis
Different cutoffs have been used in literature to define hypoglycemia in ICU patients. These range from lower than 81 mg/dL to lower than 40 mg/dL. Generally, blood glucose concentration below 60 mg/dL is considered to be hypoglycemia.
Normal lab values
Normal blood glucose: 80-110 mg/dL
Glucose is the obligate fuel for the brain. Glucose cannot be synthesized by the brain, and glycogen storage supplies last for only minutes. Low blood glucose will therefore result in brain damage.
Tight blood glucose control in ICU patients is associated with an increased incidence of hypoglycemia and also with increased mortality, and may occur in up to 28% of patients.
What's the evidence?
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds